Albert Bourla, PhD. CEO of Pfizer.
Dr. Bourla took charge of Pfizer in 2019 after a three decade tenure with the company. Alongside BioNTech, Pfizer produced the first COVID-19 vaccine to be deemed safe and effective in the U.S and Europe. The company has struck over $36 billion in deals for the vaccine.
John Nkengasong, PhD. Director of the Africa Centres for Disease Control and Prevention.
As a trained virologist with 30 years of experience in public health, Dr. Nkengasong was well-equipped to advise African nations on both COVID-19 and Ebola. He played an important role during the COVID-19 pandemic, liaising across multinational entities and nation states to acquire 400 million vaccine doses for the continent.
One to watch for 2022: Avani Singh. CEO of SpiceHealth
Ms. Singh is only 25 years old but is pioneering cheap COVID-19 testing in India. Her company created a PCR COVID-19 test one-fifth of the price in New Delhi at $6.71. She plans to serve remote communities in India by providing cheap tests in mobile lab facilities.
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.
